These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14615803)

  • 1. Risk assessment and management of cardiovascular disease in New Zealand.
    Williams M
    N Z Med J; 2003 Nov; 116(1185):U661. PubMed ID: 14615803
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations.
    Durrington PN
    BMJ; 2000 Jul; 321(7254):174-5. PubMed ID: 10950540
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of ethnicity data in primary care and its impact on cardiovascular risk assessment and management--PREDICT CVD-8.
    Riddell T; Lindsay G; Kenealy T; Jackson R; Crengle S; Bramley D; Wells S; Marshall R
    N Z Med J; 2008 Sep; 121(1281):40-8. PubMed ID: 18797483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U662. PubMed ID: 14615804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T; Jackson RT; Wells S; Broad J; Bannink L
    N Z Med J; 2007 Mar; 120(1250):U2445. PubMed ID: 17339901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
    Stewart RA; North FM; Sharples KJ; Simes RJ; Tonkin AM; White HD;
    N Z Med J; 2008 Feb; 121(1269):11-23. PubMed ID: 18278078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease risk profile tools and new zealand--the best way forward?
    Boland P; Moriarty H
    J Prim Health Care; 2009 Dec; 1(4):328-31. PubMed ID: 20690346
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U663. PubMed ID: 14615805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forward.
    Wells S; Riddell T; Jackson R
    J Prim Health Care; 2010 Jun; 2(2):168-9. PubMed ID: 20695051
    [No Abstract]   [Full Text] [Related]  

  • 16. Turning the tide of inequalities in heart health.
    Sharpe N; O'Sullivan L
    N Z Med J; 2006 Jul; 119(1238):U2085. PubMed ID: 16868582
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trading PREDICTions.
    Cox B
    N Z Med J; 2007 Sep; 120(1261):U2707. PubMed ID: 17853929
    [No Abstract]   [Full Text] [Related]  

  • 19. Gaps in primary care documentation of cardiovascular risk factors.
    Rafter N; Wells S; Stewart A; Selak V; Whittaker R; Bramley D; Roseman P; Furness S; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):24-33. PubMed ID: 18278079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.